Dopaminergic Approaches to Antipsychotic Agents
Authors:
- John M. SchausJSJohn M. Schaus
- Frank P. BymasterFBFrank P. Bymaster
- 1 January 1998
- book chapter
- Published by Elsevier
- p. 1-10
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- GRID/GOLPE 3D Quantitative Structure−Activity Relationship Study on a Set of Benzamides and Naphthamides, with Affinity for the Dopamine D3 Receptor SubtypeJournal of Medicinal Chemistry, 1997
- Mechanism of Clozapine-Induced AgranulocytosisCNS Drugs, 1997
- 4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonistsBioorganic & Medicinal Chemistry Letters, 1996
- Putative atypical antipsychotics with mixed dopaminergic (D1, D2) and serotonergic (5HT2) activity: The design evolution of ZD3638Bioorganic & Medicinal Chemistry Letters, 1995
- 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873)Journal of Medicinal Chemistry, 1995
- Binding of 5H-Dibenzo[a,d]cycloheptene and Dibenz[b,f]oxepin Analogs of Clozapine to Dopamine and Serotonin ReceptorsJournal of Medicinal Chemistry, 1995
- Binding of 5H-Dibenzo[b,e][1,4]diazepine and Chiral 5H-Dibenzo[a,d]cycloheptene Analogs of Clozapine to Dopamine and Serotonin ReceptorsJournal of Medicinal Chemistry, 1994
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976